A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer (Q51072895)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 11 April 2013

Language	Label	Description	Also known as
English	A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer	scientific article published on 11 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

Grant D. Stewart

6

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

7

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

author name string

T Powles

1

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

I Kayani

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

K Sharpe

3

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

L Lim

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

J Peters

5

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

A Sahdev

8

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

S Chowdhury

9

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

E Boleti

10

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

J Shamash

11

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

A R Reynolds

12

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

R Jones

13

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

C Blank

14

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

J Haanen

15

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

A Bex

16

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

publication date

11 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

24

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

8

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

2098-2103

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Contrasting effects of sunitinib within in vivo models of metastasis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT130

21 January 2018

Identifiers

10.1093/ANNONC/MDT130

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23579815

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51072895&oldid=2267006295"